Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Mesoblast Limited (MESO) – Mesoblast Limited Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Mesoblast (MESO) trades at $13.97, up 1.6% on the day, while technical indicators signal a bearish trend. The company reported significant net losses of -$102.14M in 2025, with a negative net income margin of -144.33%, though it maintains a high gross margin of 80.52%. Recent news highlights commercial progress, including Ryoncil net revenues of $30.3M for the March quarter and key regulatory milestones for its chronic low back pain and Duchenne muscular dystrophy trials.
The outlook is speculative with high risk-reward. Investment opportunity lies in the potential success of late-stage clinical trials and commercial ramp of Ryoncil, supported by a 'Buy' analyst consensus. Major risks include sustained cash burn, dependence on clinical outcomes, and the high P/S ratio of 30.52 despite current losses.
Read full analysis

Key Stats

  • Market Cap
    $1.87B
  • Sector
    Technology
  • 3M Drawdown
    -17.22%
  • Enterprise Value
    $1.87B
  • Dividend Yield
    -
  • Typical Hold Time
    12 days
$14.37
52W Low: $10.16
23 Jun 2025
52W High: $20.96
09 Jan 2026

Mesoblast Limited (MESO) is currently valued at a market capitalization of $1.87B, with an enterprise value of $1.87B. Over the past 52 weeks, Mesoblast Limited has traded between a low of $10.16 and a high of $20.96, highlighting its annual price range. Over the past three months, Mesoblast Limited has recorded a drawdown of -17.22%, reflecting recent price volatility. On average, investors hold Mesoblast Limited for approximately 12 days, indicating typical investor behavior on the platform.

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.


People also bought


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $1.87B
  • Sector
    Technology
  • 3M Drawdown
    -17.22%
  • Enterprise Value
    $1.87B
  • Dividend Yield
    -
  • Typical Hold Time
    12 days
$14.37
52W Low: $10.16
23 Jun 2025
52W High: $20.96
09 Jan 2026

Mesoblast Limited (MESO) is currently valued at a market capitalization of $1.87B, with an enterprise value of $1.87B. Over the past 52 weeks, Mesoblast Limited has traded between a low of $10.16 and a high of $20.96, highlighting its annual price range. Over the past three months, Mesoblast Limited has recorded a drawdown of -17.22%, reflecting recent price volatility. On average, investors hold Mesoblast Limited for approximately 12 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!